The requirements for assessing irritation is now moved from ISO 10993-10 to ISO 10993-23 and with this new standard comes the inclusion of in vitro irritation testing. As we move further to reduce animal testing and incorporate the 3 R’s (replace, reduce, refine) into biocompatibility assessment for medical devices, this is a critical turning point. Join us for an intense and informative discussion on this standard and learn what steps to take to incorporate this testing into your biocompatibility program.
- Review of the in vitro testing method
- When to pursue in vitro or in vivo testing
- How to transition from in vivo to in vitro testing
- Current regulatory acceptance